References
Liu J. FK-506 and cyclosporine, molecular probes for studying intracellular signal transduction. Immunol Today 1993;14:290–5.
Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK-506. Immunol Today 1992;13:136–42.
Flanagan MW, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991;352:803–7.
Karlsson KA. Glycobiology: a growing field for drug design. Trends Pharmacol Sci 1991;1:12–75.
Perper RJ, Alvarez B, Colombo C, Schroder H. The use of a standardized adjuvant arthritis assay to differentiate between anti-inflammatory and immunosuppressive agents. Proceed Soc Exp Bio Med 1971;137:506–12.
Meiser BM, Morris RE. The importance of the spleen for the immunosuppressive action of cyclosporin in transplantation. Transpl 1991;51:690–6.
Porayko MK, Textor SC, Krom RAF, Hay JE, Gores GJ, Wahlstrom HE, et al. Nephrotoxicity of FK-506 and cyclosporin when used as primary immunosuppression in liver transplant recipients. Transpl Proceed 1993;25:665–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koch, K., Hanson, D.C., Newborg, M.F. et al. CP-123,369: A potent, orally active immunosuppressive agent. Inflamm Res 44 (Suppl 2), S183–S184 (1995). https://doi.org/10.1007/BF01778322
Issue Date:
DOI: https://doi.org/10.1007/BF01778322